Where do Kymera Therapeutics's ratios come from?

Every ratio is computed from Kymera Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	-697.7%+193pp	-891.1%-131pp	-759.7%-62.2pp	-697.5%-225pp	-472.5%+83.3pp
Net margin	-612%+182pp	-794.1%-119pp	-674.8%-58.8pp	-616%-207pp	-409.1%+66.5pp
Returns
Return on equity	-27.1%-1.3pp	-25.8%+6.3pp	-32.1%+1.2pp	-33.3%-1.1pp	-32.2%+4.2pp
Return on invested capital	-31.8%+1.3pp	-33.1%+4.0pp	-37.1%+6.5pp	-43.6%-6.3pp	-37.3%+7.2pp
Efficiency
Asset turnover	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0.1×0.0×
Liquidity
Current ratio	10.8×+0.3×	10.5×+3.1×	7.4×-0.9×	8.3×-0.2×	8.5×+1.0×
Leverage
Debt-to-equity	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Per Share
Book value per share	$15.79-15.6%	$18.70+72.5%	$10.84-10.2%	$12.08+23.1%	$9.81-11.9%
Valuation
Market capitalization	$6.8B+9.2%	$6.22B+53.8%	$4.05B+31.8%	$3.07B+72.7%	$1.78B-31.8%
Price / sales	132.1×-26.7×	158.8×+66.2×	92.5×+23.9×	68.7×+38.5×	30.2×-25.2×
Price / book	4.4×+0.5×	3.9×-0.3×	4.3×+1.1×	3.2×+0.9×	2.3×-0.9×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Kymera Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Kymera Therapeutics's ratios come from?: Every ratio is computed from Kymera Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.